Reports

Sale

Cryopreservation for In-Vitro Fertilization (IVF) Market

Global Cryopreservation for In-Vitro Fertilization (IVF) Market: By Type: Cryopreservation Media, Cryopreservation Storage Devices, Consumables, Accessories, Cryo-shipping, Others; By Applications; By End User; Regional Analysis; Market Dynamics; Patent Analysis; Grants Analysis; Supplier Landscape; 2024-2032

Global Cryopreservation for In-Vitro Fertilization (IVF) Market Outlook

The global cryopreservation for in-vitro fertilization (IVF) market size was valued at USD 456.23 million in 2023 with the rising incidence of infertility and increased understanding on egg freezing. The market is expected to grow at a CAGR of 10.6% during the forecast period of 2024-2032, with the values likely to rise from USD 504.58 million in 2024 to USD 1129.73 million by 2032.

 

Cryopreservation for In-Vitro Fertilization (IVF): Introduction

Cryopreservation is the process of freezing and storing eggs (oocytes), sperms, or embryos for future use. It can help people preserve their future fertility. Cryopreservation is generally advised to people undergoing chemotherapy and radiations as these treatments can damage a person’s fertility. People engrossed in career also consider cryopreservation as it offers an opportunity to them to have a child later. The rising prevalence of fertility issues and the consequent rise in the demand for IVF is anticipated to provide significant impetus to the cryopreservation for in-vitro fertilization (IVF) market growth in the coming years.

 

Cryopreservation is done with the help of liquid nitrogen, freezing the cells to -320 degrees Fahrenheit. The cells are then stored in a lab or commercial reproductive medicine centres safely and can be preserved up to ten years or longer. Labs mostly use cryoprotective agents like glycols to prevent the cells from damage.

 

Global Cryopreservation for In-Vitro Fertilization (IVF) Market Analysis

Nowadays, majority of women are facing infertility problems due to a variety of factors like hectic lifestyles, food habits, and lack of exercise. The prevalence of these issues can also be attributed to invasive cancer treatments, declining oocyte quality with age, polycystic ovary syndrome (PCOS), or premature ovarian failure (POF). As per recent trends, most women prefer delaying childbearing until 35 years or later. Hence, cryopreservation for in-vitro fertilization (IVF) market demand has increased over the years.

 

Breast cancer is the common type of cancer affecting most women in their reproductive age. Talking about the United States alone, 15%  of the women affected with breast cancer are under 45 years of age. As they undergo chemotherapy regimens, cyclophosphamide, which is the common alkylating agent in chemotherapy, deteriorates the ovarian follicle reserve. Breast cancer is the most common type of cancer in women, accounting for 12.5%  of the total new cancer cases annually. With the rising incidence rate of breast cancer, the cryopreservation for in-vitro fertilization (IVF) market value is also expected to increase during the forecast period.

 

Cryopreservation is done via two processes, namely slow freezing, and vitrification. Despite successful cryopreservation outcomes, there are still high chances of DNA deformation, chromosomal abnormalities, and spindle deformation. There has been critical research around the decreasing the anomaly rates. Currently, ovarian tissue cryopreservation is under investigation. It allows the benefits of preserving thousands of primordial follicles at a time. This technique emerges to serve women with hormone-sensitive cancers as well.

 

Global Cryopreservation for In-Vitro Fertilization (IVF) Market Segmentation

Market Breakup by Type

  • Cryopreservation Media
  • Cryopreservation Storage Devices
  • Consumables
  • Accessories
  • Cryo-shipping
  • Others

 

Market Breakup by Applications

  • Oocyte Cryopreservation
  • Sperm Cryopreservation
  • Embryo Cryopreservation
  • Others

 

Market Breakup by End User

  • Biobanks
  • IVF Centres
  • Fertility Clinics
  • Research and Academic Institutes
  • Cryo-shipping/ Couriers

 

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

 

Global Cryopreservation for In-Vitro Fertilization (IVF) Market Overview

The cause of in-vitro fertilization has been redefined with the passage of time. Initially, it was used to treat infertile couples, but now the utility has expanded to fertility preservation. The overall access and utilization of IVF varies across the globe, but around 5% of the newborns in the European region are an outcome of an in-vitro fertilisation procedure.

 

With evolving socio-cultural demographics, there is a rising trend of fertility preservation, especially with women getting educated and excelling in their careers. In metropolitan areas, the average age of a woman bearing the first child has exceeded to 30s, which earlier used to be around 20s. The trend seems to continue in the coming years with the population being more aware about the expenses of raising a child and the need for planning and preparation.

 

The constant debate around cryopreservation legalisation in the countries has been an obstacle in the cryopreservation for in-vitro fertilization (IVF) market growth but it is gradually becoming a norm, especially in the metropolitan cities. Recently, cryopreservation has been legalised in countries like Taiwan, Japan, Singapore, and South Korea. This indicates that the Asian territory is likely to hold a massive portion of the global cryopreservation for in-vitro fertilization (IVF) market share in the coming years.

 

Global Cryopreservation for In-Vitro Fertilization (IVF) Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

 

  • Cryotech
  • Cook Medical LLC
  • Fujifilm Irvine Scientific
  • Thermo Fisher Scientific Inc
  • Coldstash Inc.
  • Vitromed GmbH
  • Corning Incorporated
  • Cryogatt Systems Ltd
  • Brook Life Sciences
  • Cryo Solutions B.V

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Type
  • Applications
  • End User
  • Region
Breakup by Type
  • Cryopreservation Media
  • Cryopreservation Storage Devices
  • Consumables
  • Accessories
  • Cryo-shipping
  • Others
Breakup by Applications
  • Oocyte Cryopreservation
  • Sperm Cryopreservation
  • Embryo Cryopreservation
  • Others
Breakup by End User
  • Biobanks
  • IVF
  • Fertility Clinics
  • Research and Academic Institutes
  • Cryo-shipping/ Couriers
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Cryotech
  • Cook Medical LLC
  • Fujifilm Irvine Scientific
  • Thermo Fisher Scientific Inc
  • Coldstash Inc.
  • Vitromed GmbH
  • Corning Incorporated
  • Cryogatt Systems Ltd
  • Brook Life Sciences
  • Cryo Solutions B.V.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions
    1.3    Report Coverage – Key Segmentation and Scope 
    1.4    Research Methodology
2    Executive Summary
3    Global Cryopreservation for in-vitro fertilization (IVF) market Overview
 
    3.1    Global Cryopreservation for in-vitro fertilization (IVF) market Historical Value (2017-2023) 
    3.2    Global Cryopreservation for in-vitro fertilization (IVF) market Forecast Value (2024-2032)
4    Global Cryopreservation for in-vitro fertilization (IVF) market Landscape
    4.1    Global Cryopreservation for in-vitro fertilization (IVF): Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Cryopreservation for in-vitro fertilization (IVF): Product Landscape
        4.2.1    Analysis by End User
        4.2.2    Analysis by Type
        4.2.3    Analysis by Applications
5    Global Cryopreservation for in-vitro fertilization (IVF) market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model
    5.4    Key Demand Indicators 
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends  
    5.7    Value Chain Analysis
6    Global Cryopreservation for in-vitro fertilization (IVF) market Segmentation
    6.1    Global Cryopreservation for in-vitro fertilization (IVF) market by Type
        6.1.1    Market Overview
        6.1.2    Cryopreservation Media
        6.1.3    Cryopreservation Storage Devices
        6.1.4    Consumables
        6.1.5    Accessories
        6.1.6    Cryo-shipping
        6.1.7    Others
    6.2    Global Cryopreservation for in-vitro fertilization (IVF) market by Applications
        6.2.1    Market Overview
        6.2.2    Oocyte Cryopreservation
        6.2.3    Sperm Cryopreservation
        6.2.4    Embryo Cryopreservation
        6.2.5    Others
    6.3    Global Cryopreservation for in-vitro fertilization (IVF) market by End User
        6.3.1    Market Overview
        6.3.2    Biobanks
        6.3.3    IVF
        6.3.4    Fertility Clinics
        6.3.5    Research and Academic Institutes
        6.3.6    Cryo-shipping/ Couriers
    6.4    Global Cryopreservation for in-vitro fertilization (IVF) market by Region
        6.4.1    Market Overview
        6.4.2    North America
        6.4.3    Europe 
        6.4.4    Asia Pacific
        6.4.5    Latin America
        6.4.6    Middle East and Africa
7    North America Cryopreservation for in-vitro fertilization (IVF) market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Cryopreservation for in-vitro fertilization (IVF) market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Cryopreservation for in-vitro fertilization (IVF) market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Cryopreservation for in-vitro fertilization (IVF) market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Cryopreservation for in-vitro fertilization (IVF) market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Regulatory Framework
    12.1    Regulatory Overview
        12.1.1    US FDA
        12.1.2    EU EMA
        12.1.3    INDIA CDSCO
        12.1.4    JAPAN PMDA
        12.1.5    Others
13    Patent Analysis
    13.1    Analysis by Type of Patent
    13.2    Analysis by Publication year
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Patent Age
    13.5    Analysis by CPC Analysis
    13.6    Analysis by Patent Valuation 
    13.7    Analysis by Key Players
14    Grants Analysis
    14.1    Analysis by year
    14.2    Analysis by Amount Awarded
    14.3    Analysis by Issuing Authority
    14.4    Analysis by Grant Application
    14.5    Analysis by Funding Institute
    14.6    Analysis by NIH Departments
    14.7    Analysis by Recipient Organization 
15    Funding and Investment Analysis
    15.1    Analysis by Funding Instances
    15.2    Analysis by Type of Funding
    15.3    Analysis by Funding Amount
    15.4    Analysis by Leading Players
    15.5    Analysis by Leading Investors
    15.6    Analysis by Geography
16    Partnership and Collaborations Analysis
    16.1    Analysis by Partnership Instances
    16.2    Analysis by Type of Partnership
    16.3    Analysis by Leading Players
    16.4    Analysis by Geography
17    Supplier Landscape
    17.1    Cryotech 
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Cook Medical LLC 
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    Fujifilm Irvine Scientific 
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Thermo Fisher Scientific Inc 
        17.4.1    Financial Analysis
        17.4.2    Product Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Coldstash Inc. 
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    Vitromed GmbH 
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Corning Incorporated 
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Cryogatt Systems Ltd 
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Brook Life Sciences 
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Cryo Solutions B.V. 
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
18    Key Opinion Leaders (KOL) Insights (Additional Insight)
19    Company Competitiveness Analysis (Additional Insight)

    19.1    Very Small Companies
    19.2    Small Companies
    19.3    Mid-Sized Companies
    19.4    Large Companies
    19.5    Very Large Companies
20    Payment Methods (Additional Insight)
    20.1    Government Funded
    20.2    Private Insurance
    20.3    Out-of-Pocket


*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

The market attained a value of about USD 456.23 million in 2023, driven by rising cases of infertility and increased awareness regarding reproductive health and cryopreservation.

The market is anticipated to grow at a CAGR of 10.6% during the forecast period of 2024-2032, likely to reach a market value of USD 1129.73 million by 2032.

There have been technical advancements in the current cryopreservation techniques. For example, vitrification is now an improved process with better success rates. As a result, people have started trusting the procedure more, driving the global demand further.

Countries like Taiwan, Singapore, Japan have recently lifted cryopreservation bans, allowing individuals to preserve their gametes for future use. This can drive cryopreservation demand in the Asian territory.

Products and devices used in cryopreservation include cryopreservation media, cryopreservation storage devices, consumables, accessories, and cryo-shipping, among others.

Most common cryopreservation procedures are oocyte cryopreservation, sperm cryopreservation and embryo cryopreservation, among others.

The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East and Africa. North America is currently leading the global market.

The end users in the market include biobanks, IVF centres, fertility clinics, cryo-shipping/ couriers, research and academic institutes.

Key players involved in the market are Cryotech, Cook Medical LLC, Fujifilm Irvine Scientific, Thermo Fisher Scientific Inc, Coldstash Inc., Vitromed GmbH, Corning Incorporated, Cryogatt Systems Ltd, Cryo Solutions B.V., and Brook Life Sciences.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER